GlobeNewsWire
23 Dec 2025, 17:00 UTC · 47w ago
DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Impact · against what's priced in
DexCom faces significant downside risk following allegations of unauthorized FDA design changes and reliability failures in its G6 and G7 devices. iTonic and Papa John's face moderate negative pressure from new class action securities fraud lawsuits.
- DXCM−0.70
No priced-in read yet





